<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="obo:"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4a9715be-e71f-49f6-b6e2-ba7109ca7bb4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/abae99ab-abd3-4e98-94ce-13c2e98d528f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5dd2dced-99f8-47c8-9062-046ac4bcc24c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/32adbe1c-91cf-4457-aa55-895672bbca25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a38ba9ca-d92d-4881-940f-9e979813cbea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8001a4b8-a2bf-4586-a0a6-885eff89ea12">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5c996a80-e2fb-4aa2-b6a1-22cc9c265559">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/999a7d05-deb7-480c-8935-265315282188"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d26301d0-14ba-4ce8-9321-f109a9f32970"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2156ec05-1fb6-44ac-9bdf-9f6ada3fce0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1a0cae88-998e-490c-b50f-59c754eb941f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fe49ee63-2bc3-4459-9177-8010a71ae019">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/70a1c37f-f09f-498a-bad0-d8934d9c79bf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7a10e091-b0b4-4ba0-984c-d8b3d008dc45"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/876167ba-abfb-4a95-a5f6-4a487b573433"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4a9715be-e71f-49f6-b6e2-ba7109ca7bb4"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4c3c4772-9a84-4a65-aeca-7c089d401fa4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/57d7841c-5a21-47b1-8c45-866a07ba809f">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1a0cae88-998e-490c-b50f-59c754eb941f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/72d2630c-1c06-4ce6-a241-e43d58463a6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000022">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000187">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3de9e5e2-59c8-41fd-a2ac-e33b3eef2df9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000221">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/70a1c37f-f09f-498a-bad0-d8934d9c79bf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8001a4b8-a2bf-4586-a0a6-885eff89ea12"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fc1572d1-1f81-433a-9e2f-9256608dd279"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f3c325be-d13f-4933-becd-7e7f65a63698">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/51296759-828e-4f93-a9c6-0aacff9b2530"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d5884b02-48b2-48de-9288-5de77a77d2b1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d623b3f0-32ff-4091-9621-74f0a22e9990"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5c996a80-e2fb-4aa2-b6a1-22cc9c265559"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c4637584-36d5-4812-bc6a-2977d6f23966"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/698e916c-4755-4a4d-a08b-a753368a25e1"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000050">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6e74686c-bfc7-464e-ae07-d068a739fc46">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2eb00f1a-acbe-4379-a2c3-f589c16059de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/876167ba-abfb-4a95-a5f6-4a487b573433">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5ede027b-cdc3-45cd-a6f5-da6eb11e021c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/20bb65b1-1ed2-494d-bda7-fd24a4941a15"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/abae99ab-abd3-4e98-94ce-13c2e98d528f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/25d7a0aa-9f5e-4c57-b878-c333d6b319e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ddabfb74-b457-4c04-b8ea-a0b6f61c030c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3649309e-7422-4991-bd8e-c65e8a51a44b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a8f237ed-dda0-4356-a74c-bd04d84ae32b">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e2105ee8-c829-4310-9fde-52db6f2387ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3649309e-7422-4991-bd8e-c65e8a51a44b">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/51296759-828e-4f93-a9c6-0aacff9b2530">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/20bb65b1-1ed2-494d-bda7-fd24a4941a15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000053">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/aa224600-6edd-42c8-9ba3-b14e5ed1b0a2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/957cc4b4-84df-4698-884d-ea23c808fe36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/999a7d05-deb7-480c-8935-265315282188">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c4637584-36d5-4812-bc6a-2977d6f23966">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4d429d20-be93-4fe1-a1f9-c0277b608db1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e4a020f8-6edc-439e-9773-7af8a69dada1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e2105ee8-c829-4310-9fde-52db6f2387ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ddabfb74-b457-4c04-b8ea-a0b6f61c030c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/698e916c-4755-4a4d-a08b-a753368a25e1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/989f30d1-dd2f-4837-bd46-f4fb430545d4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2eb00f1a-acbe-4379-a2c3-f589c16059de"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/01ed047a-5912-403c-8f95-5487ea3bddd7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4d429d20-be93-4fe1-a1f9-c0277b608db1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6e74686c-bfc7-464e-ae07-d068a739fc46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2156ec05-1fb6-44ac-9bdf-9f6ada3fce0e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e7a19131-becb-416e-bd93-08e0a175692c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b4c3830d-76f2-49cf-9c5c-94110da4432e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/957cc4b4-84df-4698-884d-ea23c808fe36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fc1572d1-1f81-433a-9e2f-9256608dd279">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/32adbe1c-91cf-4457-aa55-895672bbca25"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d623b3f0-32ff-4091-9621-74f0a22e9990">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/999a7d05-deb7-480c-8935-265315282188"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3591beac-135e-4453-ba73-f745a9388d0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5ede027b-cdc3-45cd-a6f5-da6eb11e021c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0811409f-a236-4ea9-83d4-22dbc5773cce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4c3c4772-9a84-4a65-aeca-7c089d401fa4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6e299f72-b98b-4b52-8a94-eed59191f0be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/234c4770-2d9c-4092-9d14-4210dda9bd48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7a10e091-b0b4-4ba0-984c-d8b3d008dc45">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8001a4b8-a2bf-4586-a0a6-885eff89ea12"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f3c325be-d13f-4933-becd-7e7f65a63698"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3591beac-135e-4453-ba73-f745a9388d0c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ecbd7362-ff18-46d0-ac3c-a1ed10d40c2d"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/25aec3b5-50d7-4aee-8cc3-946543bb79a0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/234c4770-2d9c-4092-9d14-4210dda9bd48"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/450406de-5c43-48c7-bee9-a1a1bc54e75c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ecbd7362-ff18-46d0-ac3c-a1ed10d40c2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5dd2dced-99f8-47c8-9062-046ac4bcc24c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/989f30d1-dd2f-4837-bd46-f4fb430545d4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/25aec3b5-50d7-4aee-8cc3-946543bb79a0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b4c3830d-76f2-49cf-9c5c-94110da4432e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/60952425-0d9b-4e0b-bfb4-b0b7f342666b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0811409f-a236-4ea9-83d4-22dbc5773cce">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d26301d0-14ba-4ce8-9321-f109a9f32970">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a38ba9ca-d92d-4881-940f-9e979813cbea"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/141978d2-0226-4e4a-b002-ffdf25ee9521">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/25d7a0aa-9f5e-4c57-b878-c333d6b319e0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/141978d2-0226-4e4a-b002-ffdf25ee9521"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/aa224600-6edd-42c8-9ba3-b14e5ed1b0a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e7a19131-becb-416e-bd93-08e0a175692c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/01ed047a-5912-403c-8f95-5487ea3bddd7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a8f237ed-dda0-4356-a74c-bd04d84ae32b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/450406de-5c43-48c7-bee9-a1a1bc54e75c">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3de9e5e2-59c8-41fd-a2ac-e33b3eef2df9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e4a020f8-6edc-439e-9773-7af8a69dada1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/60952425-0d9b-4e0b-bfb4-b0b7f342666b">
    <rdf:type rdf:resource="obo:MeSH_D014635"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6e299f72-b98b-4b52-8a94-eed59191f0be">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/72d2630c-1c06-4ce6-a241-e43d58463a6e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/57d7841c-5a21-47b1-8c45-866a07ba809f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
</rdf:RDF>
